VT News
Bill Engvall

Bill Engvall

Ask VT AI
View News Summary
  • Russia tests nuclear-powered cruise missile, raising concerns over technical challenges and strategic implications.
  • Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
  • U.S. and China finalize TikTok transfer deal, part of broader agreement
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Russia tests nuclear-powered cruise missile, raising concerns over technical challenges and strategic implications.
  • Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
  • U.S. and China finalize TikTok transfer deal, part of broader agreement
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Bill Engvall

Top Topics

Trending in U.S.

World

Sport